Nipah virus vaccine: Moderna says first participant has been dosed in a Phase 1 trial
by Press Release from Outbreak News Today on (#61BDN)
NewsDesk @bactiman63 Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in a Phase 1 trial of its Nipah virus (NiV) vaccine candidate, mRNA-1215, that was developed in collaboration with the Vaccine Research Center (VRC), a division of the National Institute of Allergy and [...]
The post Nipah virus vaccine: Moderna says first participant has been dosed in a Phase 1 trial appeared first on Outbreak News Today.